A public meeting and hearing of the
Utah Department of Health
State Medicaid Drug Utilization Review Board
Thursday, April 11th, 2013
Public meeting 7:00 a.m. to 8:00 a.m.
Board Evaluation of Prior Authorization Requests 8:00 a.m. to 8:30 a.m.
Cannon Health Building - Room 125
Agenda
1. Welcome…………………………………………………………..Neal Catalano, Pharm.D., Board Chair
2. Housekeeping
a. DURB Member & Guest Roster Sign-in………………………………….Robyn Seely, Pharm.D.
b. Email Lists………………………………………………………………...Robyn Seely, Pharm.D.
c. P&T Committee Report…………………………………………………………..Lisa Hunt, R.Ph.
d. Approval of March DURB Meeting Minutes……………..Neal Catalano, Pharm.D., Board Chair
3. Overactive bladder: Urinary Antispasmodics - Anti-muscarinics………………….Joanita Lake, Pharm.D.
a. Public Comment
b. Board Discussion
Please Note:
Visitors may address the Board as time permits. To be added to the agenda, at least 7 days advance notice must be given (Thursday April 4th, 6:00 p.m.). Please contact Robyn Seely, Pharm.D.at rmseely@utah.gov (preferred) or 801-538-6841. DUR Board Meeting Agendas are posted at least 14 days in advance, at http://www.utah.gov/pmn/index.html, in the Salt Lake Tribune, in the Deseret News and at the meeting location (Department of Health Cannon Building). This is a proposed agenda. The actual meeting time may not allow for discussion of all proposed items. Agenda items not discussed in the meeting may be addressed during the next regularly scheduled meeting or during a future Board meeting. Business carried forward may be discussed at the next scheduled meeting(s). All data presented at DUR Board meetings reference gross paid claims from Utah Medicaid’s data warehouse. Final year-end dollar and unit amounts may be different due to ledger adjustment.
The Purpose of the Drug Utilization Review Board:
Utah Medicaid’s Pharmacy Department manages both a Drug Utilization Review (DUR) Board, and a Pharmacy and Therapeutics (P&T) Committee. Provisions for the DUR Board are found in the Utah Administrative Code, Title R414-60A. The P&T Committee is a sub-committee of the DUR Board and is provided for in the Utah Administrative Code, Title R414-60B. The DUR Board’s goal is to ensure appropriate, medically necessary use of medications while preventing fraud, waste, and abuse. To accomplish this, the DUR Board may recommend clinical prior authorization criteria for a medication. The P&T Committee’s goals are to establish the safety and efficacy of therapeutics classes of medications for possible inclusion on Utah Medicaid’s Preferred Drug List.
Notice of Special Accommodations (ADA)
NOTICE OF SPECIAL ACCOMMODATION DURING PUBLIC MEETINGS
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Robyn Seely at 801-538-6841.
Notice of Electronic or Telephone Participation
NOTICE OF POSSIBLE ELECTRONIC OR TELEPHONIC PARTICIPATION
One or more members of the Drug Utilization Review Board may participate electronically or telephonically pursuant to UCA 52-4-7.8